Ironwood Pharmaceuticals Current Ratio 2009-2020 | IRWD

Ironwood Pharmaceuticals current ratio from 2009 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Ironwood Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-12-31 $0.50B $0.03B 15.41
2020-09-30 $0.43B $0.03B 13.17
2020-06-30 $0.37B $0.03B 14.02
2020-03-31 $0.33B $0.03B 12.10
2019-12-31 $0.31B $0.04B 7.50
2019-09-30 $0.26B $0.05B 4.88
2019-06-30 $0.22B $0.11B 1.99
2019-03-31 $0.20B $0.12B 1.70
2018-12-31 $0.27B $0.12B 2.23
2018-09-30 $0.25B $0.11B 2.21
2018-06-30 $0.28B $0.10B 2.94
2018-03-31 $0.28B $0.06B 4.42
2017-12-31 $0.31B $0.07B 4.72
2017-09-30 $0.31B $0.06B 4.87
2017-06-30 $0.34B $0.08B 4.27
2017-03-31 $0.36B $0.08B 4.54
2016-12-31 $0.38B $0.09B 4.17
2016-09-30 $0.38B $0.10B 4.02
2016-06-30 $0.39B $0.09B 4.24
2016-03-31 $0.50B $0.08B 6.35
2015-12-31 $0.50B $0.08B 6.54
2015-09-30 $0.51B $0.07B 7.46
2015-06-30 $0.53B $0.06B 8.49
2015-03-31 $0.26B $0.06B 4.41
2014-12-31 $0.29B $0.06B 4.76
2014-09-30 $0.30B $0.05B 5.63
2014-06-30 $0.33B $0.04B 7.83
2014-03-31 $0.37B $0.04B 9.64
2013-12-31 $0.23B $0.04B 5.58
2013-09-30 $0.28B $0.04B 6.95
2013-06-30 $0.34B $0.04B 7.64
2013-03-31 $0.28B $0.06B 4.40
2012-12-31 $0.18B $0.06B 3.36
2012-09-30 $0.20B $0.04B 5.69
2012-06-30 $0.17B $0.05B 3.38
2012-03-31 $0.21B $0.05B 3.95
2011-12-31 $0.17B $0.07B 2.57
2011-09-30 $0.18B $0.07B 2.52
2011-06-30 $0.21B $0.07B 2.94
2011-03-31 $0.23B $0.06B 3.78
2010-12-31 $0.26B $0.06B 4.02
2010-09-30 $0.26B $0.06B 4.71
2010-06-30 $0.28B $0.06B 4.93
2010-03-31 $0.31B $0.06B 5.57
2009-12-31 $0.13B $0.06B 2.33
2009-09-30 $0.12B $0.05B 2.30
2009-06-30 $0.00B 0.00
2009-03-31 $0.00B 0.00
2008-12-31 $0.11B $0.04B 2.87
2008-09-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.486B $0.390B
Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation and chronic constipation. The Company also focuses on one Phase 1 pain drug candidate and multiple preclinical programs, as well as on building a specialty biochemicals business based on a proprietary strain-development platform. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.765B 40.32
Takeda Pharmaceutical (TAK) Japan $52.682B 9.66
Astellas Pharma (ALPMY) Japan $29.537B 18.24
Eisai (ESALY) Japan $20.586B 22.83
Catalent (CTLT) United States $19.356B 51.22
Grifols, S.A (GRFS) Spain $11.180B 12.80
Neurocrine Biosciences (NBIX) United States $10.288B 23.86
Jazz Pharmaceuticals (JAZZ) Ireland $9.465B 15.81
Arrowhead Pharmaceuticals (ARWR) United States $8.268B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.603B 0.00
United Therapeutics (UTHR) United States $7.447B 14.46
Ionis Pharmaceuticals (IONS) United States $7.381B 0.00
IPSEN SA ADR (IPSEY) France $7.175B 0.00
Evotec AG (EVTCY) Germany $6.372B 430.30
Orion OYJ (ORINY) Finland $5.794B 0.00
Sage Therapeutics (SAGE) United States $4.962B 0.00
ChemoCentryx (CCXI) United States $4.695B 0.00
FibroGen (FGEN) United States $4.553B 0.00
Tilray (TLRY) Canada $4.184B 0.00
Nektar Therapeutics (NKTR) United States $4.071B 0.00
PTC Therapeutics (PTCT) United States $3.896B 0.00
Cronos Group (CRON) Canada $3.765B 0.00
Hypermarcas (HYPMY) Brazil $3.659B 14.44
Pacira BioSciences (PCRX) United States $3.193B 54.44
Revolution Medicines (RVMD) United States $3.032B 0.00
Corcept Therapeutics (CORT) United States $2.950B 29.59
Xencor (XNCR) United States $2.855B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.735B 16.94
AlloVir (ALVR) United States $2.380B 0.00
Sundial Growers (SNDL) Canada $2.077B 0.00
USANA Health Sciences (USNA) United States $2.042B 16.56
BioCryst Pharmaceuticals (BCRX) United States $1.903B 0.00
Endo (ENDP) Ireland $1.826B 2.76
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.783B 0.00
Translate Bio (TBIO) United States $1.735B 0.00
ImmunoGen (IMGN) United States $1.704B 0.00
Heron Therapeutics (HRTX) United States $1.652B 0.00
Organogenesis Holdings (ORGO) United States $1.639B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.616B 10.36
Ocular Therapeutix (OCUL) United States $1.391B 0.00
Indivior (INVVY) United States $1.316B 0.00
Zogenix (ZGNX) United States $1.181B 0.00
Trillium Therapeutics (TRIL) Canada $1.168B 0.00
Aclaris Therapeutics (ACRS) United States $1.154B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.060B 0.00
Karyopharm Therapeutics (KPTI) United States $1.031B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.995B 0.00
Vectura Group (VEGPF) United Kingdom $0.952B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Radius Health (RDUS) United States $0.873B 0.00
Aerie Pharmaceuticals (AERI) United States $0.861B 0.00
Collegium Pharmaceutical (COLL) United States $0.820B 31.04
VAXART, INC (VXRT) United States $0.783B 0.00
Esperion Therapeutics (ESPR) United States $0.765B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.701B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.701B 0.00
Chinook Therapeutics (KDNY) United States $0.697B 0.00
Altimmune (ALT) United States $0.592B 0.00
KalVista Pharmaceuticals (KALV) United States $0.590B 0.00
Rafael Holdings (RFL) United States $0.588B 0.00
Ardelyx (ARDX) United States $0.582B 0.00
Acutus Medical (AFIB) United States $0.578B 0.00
Summit Therapeutics (SMMT) United States $0.559B 0.00
Molecular Templates (MTEM) United States $0.545B 0.00
Flexion Therapeutics (FLXN) United States $0.543B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.503B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.501B 0.00
Akebia Therapeutics (AKBA) United States $0.500B 0.00
Harpoon Therapeutics (HARP) United States $0.490B 0.00
Siga Technologies (SIGA) United States $0.489B 13.74
AVITA Medical (RCEL) United States $0.470B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.469B 0.00
TherapeuticsMD (TXMD) United States $0.456B 0.00
DURECT (DRRX) United States $0.451B 0.00
PROFOUND MEDICL (PROF) Canada $0.445B 0.00
Jounce Therapeutics (JNCE) United States $0.438B 0.00
MEI Pharma (MEIP) United States $0.422B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.403B 10.51
Redhill Biopharma (RDHL) Israel $0.395B 0.00
VYNE Therapeutics (VYNE) United States $0.383B 0.00
Innate Pharma SA (IPHYF) France $0.356B 0.00
Nature's Sunshine Products (NATR) United States $0.324B 20.86
CASI Pharmaceuticals (CASI) United States $0.305B 0.00
Alpine Immune Sciences (ALPN) United States $0.279B 0.00
Xeris Pharmaceuticals (XERS) United States $0.267B 0.00
Onconova Therapeutics (ONTX) United States $0.258B 0.00
Oncternal Therapeutics (ONCT) United States $0.255B 0.00
Lannett Co Inc (LCI) United States $0.251B 8.42
Jaguar Animal Health (JAGX) United States $0.247B 0.00
CTI BioPharma (CTIC) United States $0.245B 0.00
IMV INC (IMV) Canada $0.223B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.219B 0.00
Concert Pharmaceuticals (CNCE) United States $0.215B 0.00
Novan (NOVN) United States $0.214B 0.00
Calithera Biosciences (CALA) United States $0.206B 0.00
OptiNose (OPTN) United States $0.202B 0.00
Iterum Therapeutics (ITRM) Ireland $0.199B 0.00
Taiwan Liposome (TLC) Taiwan $0.198B 0.00
Qilian Holding Group (QLI) China $0.197B 0.00
Infinity Pharmaceuticals (INFI) United States $0.195B 0.00
Nutriband (NTRB) United States $0.194B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.183B 0.00
Heat Biologics (HTBX) United States $0.182B 0.00
KemPharm (KMPH) United States $0.179B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.171B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.170B 0.00
Aziyo Biologics (AZYO) United States $0.163B 0.00
Genocea Biosciences (GNCA) United States $0.163B 0.00
Champions Oncology (CSBR) United States $0.156B 0.00
Aquestive Therapeutics (AQST) United States $0.154B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.150B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.143B 0.00
Otonomy (OTIC) United States $0.141B 0.00
MediWound (MDWD) Israel $0.139B 0.00
Lipocine (LPCN) United States $0.131B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.116B 0.00
ProPhase Labs (PRPH) United States $0.116B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.104B 0.00
Natural Alternatives (NAII) United States $0.100B 27.09
ElectroCore (ECOR) United States $0.099B 0.00
Assertio Holdings (ASRT) United States $0.097B 0.00
Baudax Bio (BXRX) United States $0.095B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.094B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.084B 0.00
Recro Pharma (REPH) United States $0.081B 0.00
PolarityTE (PTE) United States $0.078B 0.00
Biomerica (BMRA) United States $0.072B 0.00
Addex Therapeutics (ADXN) Switzerland $0.071B 0.00
CV Sciences (CVSI) United States $0.069B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.068B 0.00
Inhibikase Therapeutics (IKT) United States $0.067B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.065B 0.00
Brickell Biotech (BBI) United States $0.064B 0.00
Sigyn Therapeutics (SIGY) United States $0.062B 0.00
Plus Therapeutics (PSTV) United States $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 26.15
Regulus Therapeutics (RGLS) United States $0.049B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.043B 0.00
Neos Therapeutics (NEOS) United States $0.042B 0.00
RXi Pharmaceuticals (PHIO) United States $0.040B 0.00
Mannatech (MTEX) United States $0.037B 5.47
China SXT Pharmaceuticals (SXTC) China $0.030B 0.00
Midatech Pharma (MTP) United Kingdom $0.029B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.026B 0.00
Cyanotech (CYAN) United States $0.023B 19.00
Bellicum Pharmaceuticals (BLCM) United States $0.022B 0.00
JanOne (JAN) United States $0.020B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.015B 0.00
SHINECO INC (TYHT) China $0.013B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00